Literature DB >> 22528461

Searching for new genetic variations in expression databases for the GABAergic and glutamatergic systems.

Manuela Barbosa Rodrigues de Souza1, João Ricardo Mendes de Oliveira.   

Abstract

Changes in gene expression and genetic variations in coding regions have likely functional impact, potentially associated with complex diseases, such as neuropsychiatric conditions. A current need for high throughput analysis of genomic data is leading to the development and improvement of sophisticated bioinformatics approaches, which allows the processing of large amounts of sequence and gene expression data. In this study, we identified new potential genetic variations prioritizing genes related to glutamatergic and GABAergic systems, using different bioinformatics resources. The CLCbio Workbench Combined platform was initially used to build expressed sequence tags and mRNA files retrieved, respectively, from the Goldenpath and National Center for Biotechnology Information databases and latter to perform multiple batches of Smith-Waterman alignments. The PMUT software was used to increase an accurate association between potential variations and pathogenic predictions. The annotation revealed various classes of variations and most of them are deletions ranging from 1 to 7 bp. Bioinformatic pipelines seem to be useful approaches to help screening for genetic variations with potential impact in gene expression. Further analysis will foster this aim to provide celerity at the massive analysis of data currently generated in large scale high throughput experiments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528461     DOI: 10.1007/s12031-012-9771-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  32 in total

1.  Analysis of the serotonin transporter polymorphism (5-HTTLPR) in Brazilian patients affected by dysthymia, major depression and bipolar disorder.

Authors:  J R Oliveira; D R Carvalho; D Pontual; R M Gallindo; E B Sougey; V Gentil; B Lafer; L G Maia; M A Morais; S Matioli; H Vallada; R A Moreno; A Nishimura; P A Otto; M R Passos-Bueno; M Zatz
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

Review 2.  Structural variation in the human genome.

Authors:  Lars Feuk; Andrew R Carson; Stephen W Scherer
Journal:  Nat Rev Genet       Date:  2006-02       Impact factor: 53.242

3.  gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.

Authors:  Qiuying Shen; Rachnanjali Lal; Beth A Luellen; John C Earnheart; Anne Milasincic Andrews; Bernhard Luscher
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

4.  Population and computational analysis of the MGEA6 P521A variation as a risk factor for familial idiopathic basal ganglia calcification (Fahr's disease).

Authors:  Roberta R Lemos; Danyllo F Oliveira; Mayana Zatz; João R M Oliveira
Journal:  J Mol Neurosci       Date:  2010-09-14       Impact factor: 3.444

5.  Association between a GABRB3 polymorphism and autism.

Authors:  J D Buxbaum; J M Silverman; C J Smith; D A Greenberg; M Kilifarski; J Reichert; E H Cook; Y Fang; C-Y Song; R Vitale
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

6.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.

Authors:  P V Choudary; M Molnar; S J Evans; H Tomita; J Z Li; M P Vawter; R M Myers; W E Bunney; H Akil; S J Watson; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

7.  Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.

Authors:  Adolfo Sequeira; Firoza Mamdani; Carl Ernst; Marquis P Vawter; William E Bunney; Veronique Lebel; Sonia Rehal; Tim Klempan; Alain Gratton; Chawki Benkelfat; Guy A Rouleau; Naguib Mechawar; Gustavo Turecki
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

8.  Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.

Authors:  Tomoko Tsunoka; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Takenori Okumura; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-04-19       Impact factor: 5.067

Review 9.  Autism and familial major mood disorder: are they related?

Authors:  Robert DeLong
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

10.  Using structural bioinformatics to investigate the impact of non synonymous SNPs and disease mutations: scope and limitations.

Authors:  Joke Reumers; Joost Schymkowitz; Fréderic Rousseau
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.